• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Potential Utility of Laser Speckle Contrast Imaging to Detect Early Microcirculatory Changes Associated With Erythema Nodosum in Crohn's Disease: A Case Report.激光散斑对比成像检测克罗恩病中与结节性红斑相关的早期微循环变化的潜在效用：一例报告
Inflamm Bowel Dis. 2025 May 12;31(5):1471-1472. doi: 10.1093/ibd/izae284.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006097. doi: 10.1002/14651858.CD006097.
4
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006097. doi: 10.1002/14651858.CD006097.pub2.
5
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
6
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.维多珠单抗用于儿童炎症性肠病的维持治疗（VEDOKIDS）：一项多中心、前瞻性队列研究的54周结果
Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6.
7
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
8
Epidemiology and Steroid Dependency Reduction in Crohn's Disease During the Biologics Era: A Nationwide Population-Based Study.生物制剂时代克罗恩病的流行病学及类固醇依赖减少：一项基于全国人口的研究
Adv Ther. 2025 Jun 23. doi: 10.1007/s12325-025-03245-0.
9
Glutamine for induction of remission in Crohn's disease.谷氨酰胺用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD007348. doi: 10.1002/14651858.CD007348.pub2.
10
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study.外周血DNA甲基化特征用于预测克罗恩病成年患者生物治疗反应的开发与验证（EPIC-CD）：一项全表观基因组关联研究
Lancet Gastroenterol Hepatol. 2025 Jul 1. doi: 10.1016/S2468-1253(25)00102-5.

本文引用的文献

1
Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.炎症性肠病的皮肤表现：基本特征、治疗和潜在的病理生理学关联。
Front Immunol. 2023 Oct 26;14:1234535. doi: 10.3389/fimmu.2023.1234535. eCollection 2023.
2
Applications of Laser Speckle Contrast Imaging Technology in Dermatology.激光散斑对比成像技术在皮肤病学中的应用
JID Innov. 2023 Jan 24;3(5):100187. doi: 10.1016/j.xjidi.2023.100187. eCollection 2023 Sep.
3
Perfusion measured by laser speckle contrast imaging as a predictor for expansion of psoriasis lesions.激光散斑对比成像测量的灌注作为预测银屑病皮损扩张的指标。
Skin Res Technol. 2022 Jan;28(1):104-110. doi: 10.1111/srt.13098. Epub 2021 Oct 7.
4
Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.炎症性肠病患者的皮肤表现：发病机制、临床特征和治疗。
Inflamm Bowel Dis. 2014 Jan;20(1):213-27. doi: 10.1097/01.MIB.0000436959.62286.f9.

Potential Utility of Laser Speckle Contrast Imaging to Detect Early Microcirculatory Changes Associated With Erythema Nodosum in Crohn's Disease: A Case Report.

作者信息

Yang EunMee, Wayne Peter M, Ahn Andrew C, Korzenik Joshua

机构信息

Division of Preventive Medicine, Osher Center for Integrative Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Division of Gastroenterology, Hepatology, and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Inflamm Bowel Dis. 2025 May 12;31(5):1471-1472. doi: 10.1093/ibd/izae284.

DOI:10.1093/ibd/izae284
PMID:39607856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12069988/
Abstract
摘要